Depemokimab for treating severe eosinophilic asthma in people 12 years and over [ID6447]
In development
Reference number: GID-TA11553
Expected publication date: TBC
Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in mid-June 2025. The deadline for submissions is expected in approximately mid-August 2025 when we will write to you about how you can get involved.